RARA and acute promyelocytic leukemia: As one of the most potential drugs in APL, arsenic trioxide (As2O3, ATO) targets PML/RARα and exerts dose-dependent dual effects on APL cells, with low concentrations inducing differentiation and high concentrations triggering apoptosis [7].